Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2985561000168115 | Neostigmine Methylsulfate (AstraZeneca) (neostigmine methylsulfate 2.5 mg / 1 mL) injection, 1 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2985571000168114 | Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | has Australian BoSS | neostigmine methylsulfate | true | Inferred relationship | Some | 44426759 | |
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | Is a | Neostigmine Methylsulfate (AstraZeneca) | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | Is a | neostigmine methylsulfate 2.5 mg/mL injection, ampoule | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | has intended active ingredient | neostigmine | true | Inferred relationship | Some | 44426759 | |
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | has unit of use | ampoule | true | Inferred relationship | Some | 44426760 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | has TPUU | True | Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | has TPUU | True | Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR